drugset / Trial / NCT00652262

BAY38-9456 - Supportive Trial for Spinal Injury

NCT00652262

Phase 3 Completed 32 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

BAY 38-9456 10 mg and 20 mg can be given as safe and efficacious medications to patients with spinal cord injury suffering from erectile dysfunction, and that erectile dysfunction can be improved by uptitration to BAY 38-9456 20 mg when the treatment with 10 mg is not sufficiently effective

Timeline

Start
2004-03
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 10 mg
Subject Vardenafil Small molecule 20 mg